The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting the outcome of mCPRC patients after Lu-177 PSMA therapy using semi-quantitative and visual criteria in baseline PSMA PET: An international multicenter retrospective study.
 
Masatoshi Hotta
No Relationships to Disclose
 
Andrei Gafita
No Relationships to Disclose
 
Vishnu Murthy
No Relationships to Disclose
 
Matthias R. Benz
No Relationships to Disclose
 
Ida Sonni
No Relationships to Disclose
 
Irene Burger
Honoraria - Astellas Pharma; Bayer; GE Healthcare
Research Funding - Swiss Life Group
 
Matthias Eiber
Consulting or Advisory Role - Blue Earth Diagnostics; Janssen; POINT Biopharma; Progenics; Telix Pharmaceuticals
Patents, Royalties, Other Intellectual Property - rhPSMA
 
Louise Emmett
Honoraria - Astellas Pharma; AstraZeneca; Janssen Oncology; Mundipharma; Telix Pharmaceuticals
Consulting or Advisory Role - Noxopharm
Speakers' Bureau - Janssen Oncology; Janssen Oncology; mundipharma
Research Funding - Novartis (Inst); Novartis (Inst); Noxopharm (Inst); Noxopharm (Inst)
 
Andrea Farolfi
No Relationships to Disclose
 
Wolfgang Peter Fendler
Honoraria - Parexel
Consulting or Advisory Role - Calyx; Janssen
Speakers' Bureau - Bayer; Janssen
Research Funding - SOFIE
 
Michael S Hofman
Consulting or Advisory Role - Endocyte; Janssen; POINT Biopharma
Speakers' Bureau - Astellas Pharma; AstraZeneca; Janssen; Mundipharma
Research Funding - Advanced Accelerator Applications/Novartis (Inst); Endocyte (Inst)
Travel, Accommodations, Expenses - Genzyme; Ipsen; Janssen
 
Thomas A Hope
Research Funding - NIH; Prostate Cancer Foundation
 
Clemens Kratochwil
No Relationships to Disclose
 
Johannes Czernin
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - RayzeBio; SOFIE; Trethera
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; RayzeBio
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; Progenics; Radiomedix
Consulting or Advisory Role - Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; POINT Biopharma; Progenics; Telix Pharmaceuticals
Speakers' Bureau - IBA RadioPharma Solutions; Telix Pharmaceuticals
Research Funding - Progenics